Sesen Bio Inc expected to post a loss of 10  cents a share - Earnings Preview

Carisma Therapeutics

06/05/2022 18:43

* Sesen Bio Inc  SESN.OQ   SESN.O  is expected to show a
fall in
quarterly revenue when it reports  results on May 9
(estimated). 
    * ​Refinitiv's mean analyst estimate for Sesen Bio Inc is
for a
loss of 10 cents per share. For the same quarter last year, the
company reported a loss of 35 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Sesen Bio
Inc is
$1.85​, above​ its last closing price of $0.58. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.08       -0.07      0.04      Beat    154.5
 Sep. 30 2021  -0.08       -0.07      0.36      Beat    614.3
 Jun. 30 2021  -0.06       -0.06      -0.15     Missed  -136.9
                                                        ​
 Mar. 31 2021  -0.08       -0.08      -0.35     Missed  -356.5
 ​​Dec.        -0.11       -0.11      -0.11     Met     -3.1
 31 2020                                                
 Sep. 30 2020  -0.08       -0.08      -0.19     Missed  -137.5
                                                        ​
 Jun. 30 2020  -0.09       -0.09      -0.24     Missed  -157.2
 Mar. 31 2020  -0.08       -0.09      0.31      Beat    457.7
 This summary was machine generated May 6 at 17:43 GMT.  All
figures in US dollars  unless otherwise stated